Tag: Sotrovimab

Innovation, News, Research

FDA Allows New Antibody in Less-Severe COVID-19

May 27, 2021

Via: MedPageToday

FDA authorized another monoclonal antibody, sotrovimab, for emergency use in COVID-19 patients at high risk of severe disease, the agency announced on Wednesday. Sotrovimab received emergency use authorization (EUA) for patients 12 years and older with mild to moderate COVID-19, […]